Addexbio 细胞库 / 细胞培养

Addexbio 细胞库 / 细胞培养

Addexbio是一家总部位于美国的生物技术公司,致力于开发和提供高品质的化合物和抗体,用于支持全球的生命科学研究和药物研发等领域。该公司的产品涵盖了各种不同的研究领域,包括癌症研究、免疫学研究、细胞信号转导研究等。


AddexBio常卖产品:

货号 品名 规格 品牌
C0003003 MOLM-13 cells ea Addexbio
C0003006 LP-1 cells 1vial Addexbio
C0003016 BJAB 1vial Addexbio
T0020001 HaCaT cells 1vial Addexbio

关键词:Addexbio;MOLM-13 cells;C0003003;C0003006;细胞

AddexBio代理


AddexBio代理

简要描述:AddexBio代理,AddexBio上海代理,AddexBio北京代理,AddexBio代理,AddexBio一级代理,AddexBio代理
上海金畔生物科技有限公司AddexBio专业代理,具体产品信息欢迎电询:021-50837765

详细介绍

产品咨询

世界*实验材料供应商AddexBio上海金畔生物为其中国代理,AddexBio 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品,的服务, AddexBio 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

AddexBio 中国代理,AddexBio 上海代理,AddexBio北京代理, AddexBio 广东代理,AddexBio 江苏代理 AddexBio 湖北代理, AddexBio 天津, AddexBio 黑龙江代理, AddexBio内蒙古代理, AddexBio 吉林代理, AddexBio 福建代理, AddexBio 江苏代理, AddexBio 浙江代理, AddexBio 四川代理,

AddexBio,AddexBio细胞。。。
AddexBio专业生产菌株,可提供大量不同阶段的细胞株,涉及癌症,永生、原代、稳定细胞株,产品质量可与ATCC菌株媲美,价格更实惠!客户遍及,对AddexBio给予了高度的评价!(:www.addexbio.com)

“AddexBio细胞株SJSA-1cells(骨肉瘤;多潜能肉瘤)”

疾病: 骨肉瘤;多潜能肉瘤 

来源: 原发性股骨的原始多向肉瘤

种类: 人

组织: 骨头

Disease:

Osteosarcoma; multipotential sarcoma 

Origin:

Derived from primary tumor of a patient diagnosed with primitive multipotential sarcoma of the femur 

Species:

Homo sapiens 

Tissue:

Bone 

Morphology:

Fibroblast 

Properties:

Adherent 

Cytogenic data:

SJSA-1 cells also exhibit a 15 fold amplification of the gli proto-oncogene 

Patient:

Male, Black, 19 years of age 

Medium:

RPMI1640 + 10% FBS 

Subculture:

1:5 to 1:8 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 degree C 

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO 

Biosafety Level:

 I 

Sterility:

Bacteria: Negative 

Yeast: Negative 

Mycoplasma: Negative 

Pathogens:

HIV: Negative 

Hepatitis B: Negative 

Hepatitis C: Negative 

Isoenzymes:

 Not known 

DNA Profile (STR):

 Not known 

Mutations in SJSA-1 Cells 

References for SJSA-1 cells:

1. Bransfield, K. L., Askham, J. M., Leek, J. P., Robinson, P. A., and Mighell, A. J. Phenotypic changes associated with DYNACTIN-2 (DCTN2) over expression characterise SJSA-1 osteosarcoma cells. Mol Carcinog, 45: 157-163, 2006. 

2. Missirlis, D., Khant, H., and Tirrell, M. Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro. Biochemistry, 48: 3304-3314, 2009. 

3. Missirlis, D., Krogstad, D. V., and Tirrell, M. Internalization of p53(14-29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death. Mol Pharm, 7: 2173-2184.

上海金畔生物科技有限公司

AddexBio总 代理


AddexBio总 代理

简要描述:AddexBio代理,AddexBio上海代理,AddexBio北京代理,AddexBio代理,AddexBio一级代理,AddexBio代理
上海金畔生物科技有限公司AddexBio专业代理,具体产品信息欢迎电询:021-50837765

详细介绍

产品咨询

世界*实验材料供应商AddexBio上海金畔生物为其中国代理,AddexBio 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品,的服务, AddexBio 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

AddexBio 中国代理,AddexBio 上海代理,AddexBio北京代理, AddexBio 广东代理,AddexBio 江苏代理 AddexBio 湖北代理, AddexBio 天津, AddexBio 黑龙江代理, AddexBio内蒙古代理, AddexBio 吉林代理, AddexBio 福建代理, AddexBio 江苏代理, AddexBio 浙江代理, AddexBio 四川代理,

AddexBio,AddexBio细胞。。。
AddexBio专业生产菌株,可提供大量不同阶段的细胞株,涉及癌症,永生、原代、稳定细胞株,产品质量可与ATCC菌株媲美,价格更实惠!客户遍及,对AddexBio给予了高度的评价!(:www.addexbio.com)

“AddexBio细胞株SJSA-1cells(骨肉瘤;多潜能肉瘤)”

疾病: 骨肉瘤;多潜能肉瘤 

来源: 原发性股骨的原始多向肉瘤

种类: 人

组织: 骨头

Disease:

Osteosarcoma; multipotential sarcoma 

Origin:

Derived from primary tumor of a patient diagnosed with primitive multipotential sarcoma of the femur 

Species:

Homo sapiens 

Tissue:

Bone 

Morphology:

Fibroblast 

Properties:

Adherent 

Cytogenic data:

SJSA-1 cells also exhibit a 15 fold amplification of the gli proto-oncogene 

Patient:

Male, Black, 19 years of age 

Medium:

RPMI1640 + 10% FBS 

Subculture:

1:5 to 1:8 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37 degree C 

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO 

Biosafety Level:

 I 

Sterility:

Bacteria: Negative 

Yeast: Negative 

Mycoplasma: Negative 

Pathogens:

HIV: Negative 

Hepatitis B: Negative 

Hepatitis C: Negative 

Isoenzymes:

 Not known 

DNA Profile (STR):

 Not known 

Mutations in SJSA-1 Cells 

References for SJSA-1 cells:

1. Bransfield, K. L., Askham, J. M., Leek, J. P., Robinson, P. A., and Mighell, A. J. Phenotypic changes associated with DYNACTIN-2 (DCTN2) over expression characterise SJSA-1 osteosarcoma cells. Mol Carcinog, 45: 157-163, 2006. 

2. Missirlis, D., Khant, H., and Tirrell, M. Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro. Biochemistry, 48: 3304-3314, 2009. 

3. Missirlis, D., Krogstad, D. V., and Tirrell, M. Internalization of p53(14-29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death. Mol Pharm, 7: 2173-2184.

上海金畔生物科技有限公司